These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10494175)

  • 41. A short course of induction chemotherapy followed by two cycles of high-dose chemotherapy with stem cell rescue for chemotherapy naive metastatic breast cancer.
    Elias AD; Richardson P; Avigan D; Ibrahim J; Joyce R; Demetri G; Levine J; Warren D; Arthur T; Reich E; Wheele C; Frei E; Ayash L
    Bone Marrow Transplant; 2001 Feb; 27(3):269-78. PubMed ID: 11277174
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Role of high-dose chemotherapy with hemopoietic stem-cell support in the treatment of adult patients with high-grade glioma].
    Linassier C; Destrieux C; Benboubker L; Alcaraz L; Bergemer-Fouquet AM; Jan M; Calais G; Colombat P
    Bull Cancer; 2001 Sep; 88(9):871-6. PubMed ID: 11604360
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [High-dose chemotherapy with autologous peripheral blood stem cell transplantation for treatment of non-Hodgkin's lymphoma].
    Yamane T; Hino M; Ohta K; Koh KR; Nakamae H; Aoyama Y; Ota T; Kishida T; Mugitani A; Sannomiya Y; Kamitani T; Takubo T; Tatsumi N
    Gan To Kagaku Ryoho; 2000 Sep; 27(10):1547-55. PubMed ID: 11016000
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Stem cell transplantation in germ cell tumors].
    Linkesch W
    Acta Med Austriaca Suppl; 2000; 52():30-2. PubMed ID: 11261275
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dose-intense paclitaxel, etoposide and cyclophosphamide: a safe and active regimen for tumor cytoreduction and stem cell mobilization in metastatic breast cancer.
    Bilgrami S; Feingold JM; Bona RD; Edwards RL; Khan AM; Rodriguez-Pinero F; Khan IA; Kazierad D; Clive J; Tutschka PJ
    Bone Marrow Transplant; 2000 Jan; 25(2):123-30. PubMed ID: 10673668
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Complications of peripheral blood stem cell transplantation.
    Klumpp TR
    Semin Oncol; 1995 Jun; 22(3):263-70. PubMed ID: 7777870
    [No Abstract]   [Full Text] [Related]  

  • 47. Antimicrobial therapy of febrile complications after high-dose chemotherapy and autologous hematopoietic stem cell transplantation--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
    Weissinger F; Auner HW; Bertz H; Buchheidt D; Cornely OA; Egerer G; Heinz W; Karthaus M; Kiehl M; Krüger W; Penack O; Reuter S; Ruhnke M; Sandherr M; Salwender HJ; Ullmann AJ; Waldschmidt DT; Wolf HH
    Ann Hematol; 2012 Aug; 91(8):1161-74. PubMed ID: 22638755
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Role of high-dose chemotherapy in hematology and internal medicine/ oncology].
    Engert A; Josting A; Reiser M; Söhngen D; Diehl V
    Med Klin (Munich); 1999 Aug; 94(8):431-42. PubMed ID: 10495622
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Use of subgrafting doses of peripheral stem cells is a new approach to overcoming hematological toxicity of multiple intensive courses of chemotherapy in children].
    Iankelevich MIa; Dolgopolov IS; Andreeva LIu; Ravshanova RS; Izhogin DG; Mkheidze DM; Ogorodnikova EV; Mentkevich GL
    Vestn Ross Akad Med Nauk; 2000; (6):21-4. PubMed ID: 10943156
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Interventional antimicrobial therapy for febrile complications after high-dose chemotherapy and autologous stem cell transplantation. Standard recommendations of the Work Group of Infections in Hematology and Oncology of the German Association of Hematology and Oncology].
    Maschmeyer G; Hertenstein B; Glass B; Schiel X
    Dtsch Med Wochenschr; 1999 Apr; 124 Suppl 1():S9-13. PubMed ID: 10410649
    [No Abstract]   [Full Text] [Related]  

  • 51. [Reduction in hematotoxicity of chemotherapy using reinfusion of hematopoietic stem cells].
    van Hoef ME
    Ned Tijdschr Geneeskd; 1993 Jan; 137(5):240-4. PubMed ID: 8094541
    [No Abstract]   [Full Text] [Related]  

  • 52. High dose chemotherapy with autologous marrow rescue in the treatment of resistant solid tumors.
    LeMaistre CF; Knight WA
    Invest New Drugs; 1983; 1(4):321-9. PubMed ID: 6088420
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High-dose combination chemotherapy: why, how, and when.
    Israël L
    Mt Sinai J Med; 1985 Jun; 52(6):447-51. PubMed ID: 3875024
    [No Abstract]   [Full Text] [Related]  

  • 54. Antineoplastic chemotherapy, sweat, and the skin.
    Horn TD
    Arch Dermatol; 1997 Jul; 133(7):905-6. PubMed ID: 9236531
    [No Abstract]   [Full Text] [Related]  

  • 55. High-dose chemotherapy with blood stem-cell transplantation in the treatment of solid tumors and hematological malignancies. A one-day course in the continuing education program organized by the Tumor Center Heidelberg/Mannheim, February 1995.
    Goldschmidt H; Haas R
    J Cancer Res Clin Oncol; 1995; 121(6):383-4. PubMed ID: 7797605
    [No Abstract]   [Full Text] [Related]  

  • 56. Hematopoietic stem cell transplantation. Introduction.
    Bishop MR
    Cancer Treat Res; 2009; 144():ix-x. PubMed ID: 20695131
    [No Abstract]   [Full Text] [Related]  

  • 57. Consensus Conference on Intensive Chemotherapy Plus Hematopoietic Stem-Cell Transplantation in Malignancies: Lyon, France, June 4-6, 1993.
    Coiffier B; Philip T; Burnett AK; Symann ML
    J Clin Oncol; 1994 Jan; 12(1):226-31. PubMed ID: 7903691
    [No Abstract]   [Full Text] [Related]  

  • 58. [Growth dynamics of transplantable murine tumors in the course of dicarbamin-protected chemotherapy].
    Sedakova LA; Treshchalina EM; Sitdikova SM; Nebol'sin VE
    Vopr Onkol; 2010; 56(5):591-2, 594-6. PubMed ID: 21137241
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High-dose chemotherapy. Concepts and strategies.
    Odaimi M; Ajani J
    Am J Clin Oncol; 1987 Apr; 10(2):123-32. PubMed ID: 3551575
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Prevention and treatment of hemopoietic disorders during the chemotherapy of malignant ovarian tumors].
    Rybalka AM
    Pediatr Akus Ginekol; 1979; (5):45-6. PubMed ID: 503619
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.